🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07786376
Starting soon Observational

AI in Histipathological Diagnosis of Bcc

NCT07786376 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-10-01
Last updated
2026-08-26

Condition(s) studied

Basal Cell Cancer

Study summary

The goal of this study is to evaluate the diagnostic performance of an Artificial Intelligence (AI) algorithm in the histopathological diagnosis of bcc compared to certified dermatopathologists

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Histopathological slides diagnosed as BCC. * Slides with adequate staining and preservation allowing clear visualization of dermatopathological features. Exclusion Criteria: * Slides with poor staining quality or significant artifacts interfering with histopathological interpretation. * Slides that were damaged, faded, or inadequately preserved. * Cases with uncertain or inconclusive original diagnoses. * Slides that could not be successfully digitized due to technical limitations ex very short or too long slides.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Al hussein universty hospital Cairo Nasr City

More Al-Azhar University trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07786376 on ClinicalTrials.gov ↗ ← All trials in Egypt